Matthew M. Cooney
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research 21
- Renal cell carcinoma treatment 11
- Lung Cancer Treatments and Mutations 8
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 9
- Oncology top 1%
- Cancer Treatment and Pharmacology 16
- Vascular Tumors and Angiosarcomas 9
-
- Radiopharmaceutical Chemistry and Applications 13
-
- Multiple Myeloma Research and Treatments 9
Matthew M. Cooney
83 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Pulmonary and Respiratory Medicine 3.6k
- Cancer Research 1.1k
- Oncology 1.8k
- Radiology, Nuclear Medicine and Imaging 1.1k
- Endocrinology, Diabetes and Metabolism 578
Countries citing papers authored by Matthew M. Cooney
This map shows the geographic impact of Matthew M. Cooney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Cooney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Cooney more than expected).
Fields of papers citing papers by Matthew M. Cooney
This network shows the impact of papers produced by Matthew M. Cooney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Cooney. The network helps show where Matthew M. Cooney may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew M. Cooney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2021 | 7 | |
| 6 | 2019 | 9 | |
| 7 | 2018 | 20 | |
| 8 | 2018 | 6 | |
| 9 | Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trialbreakdown → | 2016 | 436 |
| 10 | 2014 | 3 | |
| 11 | 2012 | 7 | |
| 12 | 2011 | 27 | |
| 13 | 2010 | 13 | |
| 14 | 2009 | 17 | |
| 15 | 2008 | 10 | |
| 16 | 2008 | 18 | |
| 17 | 2008 | 23 | |
| 18 | 2008 | 24 | |
| 19 | 2005 | 8 | |
| 20 | 2004 | 1 |
About Matthew M. Cooney
Matthew M. Cooney is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 86 papers that have together received 5.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (21 papers), Cancer Treatment and Pharmacology (16 papers), Radiopharmaceutical Chemistry and Applications (13 papers), Renal cell carcinoma treatment (11 papers), Vascular Tumors and Angiosarcomas (9 papers), Multiple Myeloma Research and Treatments (9 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Lung Cancer Treatments and Mutations (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.6k citations), Cancer Research (1.1k citations) and Oncology (1.8k citations). Matthew M. Cooney has collaborated with scholars based in United States, United Kingdom and Uganda. Frequent co-authors include Jorge A. García, Robert Dreicer, Nicholas J. Vogelzang, Joel Picus, Glenn Liu, Daniel H. Shevrin, Manish Kohli, Maha Hussain, Robert S. DiPaola and Noah M. Hahn. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.